https://www.epmmagazine.com/topics/epilepsy/index.rss en-gb © Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved. Thu, 05 Mar 2020 09:29:13 -0000 The UK government has relaxed import restrictions for cannabis-based products to help ensure patients can access treatments without delay. https://www.epmmagazine.com/pharma-manufacturing-news/import-restrictions-relaxed-for-patients-requiring-medicinal/ https://www.epmmagazine.com/pharma-manufacturing-news/import-restrictions-relaxed-for-patients-requiring-medicinal/ Thu, 05 Mar 2020 09:29:13 -0000 Medicinal Cannabis Pharma company Eisai has launched a digital health solution on Amazon Alexa designed for those affected by a rare and severe form of childhood-onset epilepsy. https://www.epmmagazine.com/pharma-manufacturing-news/eisai-launches/ https://www.epmmagazine.com/pharma-manufacturing-news/eisai-launches/ Tue, 12 Nov 2019 15:50:00 -0000 Amazon Alexa Two cannabis-based medicines to treat both epilepsy and multiple sclerosis have been approved for use on the NHS for the first time. https://www.epmmagazine.com/pharma-manufacturing-news/cannabis-based-medicines-approved-on-nhs-for-first-time/ https://www.epmmagazine.com/pharma-manufacturing-news/cannabis-based-medicines-approved-on-nhs-for-first-time/ Mon, 11 Nov 2019 12:10:00 -0000 Medical cannabis Erik Janssen In this online exclusive, Erik Janssen, vice president of Global New Patient Solutions Neurology at UCB, talks about why advancements in big data and analytics might be the key to helping patients with epilepsy. https://www.epmmagazine.com/pharmaceutical-industry-insights/reaching-the-final-third-use-of-big-data-analytics-in-epilepsy/ https://www.epmmagazine.com/pharmaceutical-industry-insights/reaching-the-final-third-use-of-big-data-analytics-in-epilepsy/ Fri, 17 Aug 2018 10:32:43 -0000 Artificial intelligence The Medicines and Healthcare products Regulatory Agency (MHRA) has implemented changes to the licence for valproate medicines — Epilim, Depakote and generics used to treat epilepsy and bipolar disorder — in the interest of public safety. https://www.epmmagazine.com/pharma-manufacturing-news/mhra-changes-licence-for-valproate-medicines/ https://www.epmmagazine.com/pharma-manufacturing-news/mhra-changes-licence-for-valproate-medicines/ Tue, 24 Apr 2018 12:44:30 -0000 Epilepsy The US Food and Drug Administration (FDA) has granted orphan drug designation to Crossject's treatment for status epilepticus (epileptic seizure lasting longer than five minutes), ZENEO Midazolam. https://www.epmmagazine.com/pharma-manufacturing-news/fda-grants-orphan-drug-designation-to-zeneo-midazolam/ https://www.epmmagazine.com/pharma-manufacturing-news/fda-grants-orphan-drug-designation-to-zeneo-midazolam/ Wed, 04 Apr 2018 15:50:41 -0000 Epilepsy ribbon Cases of drug-resistant epilepsy are predicted to increase by more than 100,000 by the year 2026, according to data and analytics company, GlobalData. https://www.epmmagazine.com/pharmaceutical-industry-insights/cases-of-drug-resistant-epilepsy-set-to-rise/ https://www.epmmagazine.com/pharmaceutical-industry-insights/cases-of-drug-resistant-epilepsy-set-to-rise/ Fri, 02 Mar 2018 11:50:24 -0000 Epilepsy Data, recently published in the journal Epilepsia, has demonstrated once-daily monotherapy, Zebinix (esclicarbazeptine acetate), is non-inferior to twice-daily controlled released carbamazepine in the treatment of newly diagnosed focal epilepsy https://www.epmmagazine.com/pharma-manufacturing-news/once-daily-monotherapy-is-not-inferior-to-twice-daily-treatm/ https://www.epmmagazine.com/pharma-manufacturing-news/once-daily-monotherapy-is-not-inferior-to-twice-daily-treatm/ Fri, 02 Feb 2018 11:58:10 -0000 Epilepsy ribbon Antiepileptic drugs and the potentially harmful effects on unborn children has hit the headlines as a survey reveals many women have not received the new safety warnings about the dangers of taking it during pregnancy. https://www.epmmagazine.com/pharma-manufacturing-news/survey-reveals-new-safety-warnings-on-antiepileptics-not-rec/ https://www.epmmagazine.com/pharma-manufacturing-news/survey-reveals-new-safety-warnings-on-antiepileptics-not-rec/ Fri, 22 Sep 2017 11:22:14 -0000 Pregnancy medicines Felicity Thomas The European Medicines Agency (EMA) has approved Zebinix (eslicarbazepine acetate) for use as once-daily monotherapy to treat adults with newly-diagnosed partial-onset epilepsy. https://www.epmmagazine.com/pharma-manufacturing-news/ema-approves-once-daily-therapy-for-partial-onset-epilepsy/ https://www.epmmagazine.com/pharma-manufacturing-news/ema-approves-once-daily-therapy-for-partial-onset-epilepsy/ Thu, 25 May 2017 10:52:06 -0000 Epilepsy ECG Felicity Thomas Laurus Synthesis and Epygenix Therapeutics have signed a collaboration agreement for the development and manufacture of EPX-100, an epilepsy candidate. https://www.epmmagazine.com/pharma-manufacturing-news/collaboration-formed-for-development-of-epilepsy-candidate/ https://www.epmmagazine.com/pharma-manufacturing-news/collaboration-formed-for-development-of-epilepsy-candidate/ Mon, 03 Apr 2017 09:07:04 -0000 Epilepsy Zebinix, an anti-epileptic drug which is used as an add-on therapy for adult patients with partial-onset seizures has been shown to reduce seizure frequency. https://www.epmmagazine.com/pharma-manufacturing-news/drug-improves-epilepsy-for-people-with-partial-onset-seizure/ https://www.epmmagazine.com/pharma-manufacturing-news/drug-improves-epilepsy-for-people-with-partial-onset-seizure/ Mon, 19 Dec 2016 10:55:00 -0000 Epilepsy Emily Hughes The first 3D printed drug approved by the Food and Drug Administration (FDA) is now available for the treatment of epilepsy https://www.epmmagazine.com/pharma-manufacturing-news/first-fda-approved-3d-printed-drug-available-to-treat-epilep/ https://www.epmmagazine.com/pharma-manufacturing-news/first-fda-approved-3d-printed-drug-available-to-treat-epilep/ Mon, 28 Mar 2016 09:00:00 -0000 spritam-product-shot-1-HR.jpg Emily Hughes Epidiolex, a cannabis-based drug has been used to treat children with Dravet syndrome, a rare form of epilepsy, in GW Pharmaceutical’s (GW) phase three clinical study https://www.epmmagazine.com/pharma-manufacturing-news/children-with-rare-epilepsy-treated-with-cannabis/ https://www.epmmagazine.com/pharma-manufacturing-news/children-with-rare-epilepsy-treated-with-cannabis/ Tue, 15 Mar 2016 14:16:00 -0000 cannabis.jpg Emily Hughes UCB’s Briviact (brivaracetam) has been authorised as an add-on treatment for partial onset seizures (POS) in adults with epilepsy and is now available on the NHS https://www.epmmagazine.com/pharma-manufacturing-news/ucb-new-drug-authorised-for-epilepsy-treatment-in-uk/ https://www.epmmagazine.com/pharma-manufacturing-news/ucb-new-drug-authorised-for-epilepsy-treatment-in-uk/ Thu, 03 Mar 2016 11:57:01 -0000 epilepsy.jpg Emily Hughes The first 3D printed drug has been approved by the American Food and Drug Administration (FDA) for the treatment of epilepsy https://www.epmmagazine.com/pharma-manufacturing-news/first-3d-printed-drug-approved-by-fda/ https://www.epmmagazine.com/pharma-manufacturing-news/first-3d-printed-drug-approved-by-fda/ Wed, 04 Nov 2015 15:26:27 -0000 3D printed tablets.jpg Pfizer and Flynn Pharma stand accused of overcharging the NHS millions for an anti-epilepsy drug. https://www.epmmagazine.com/pharma-manufacturing-news/pfizer-and-flynn-in-overcharging-scandal/ https://www.epmmagazine.com/pharma-manufacturing-news/pfizer-and-flynn-in-overcharging-scandal/ Thu, 06 Aug 2015 09:19:00 -0000 Capsules The FDA has approved the first 3D printed drug, Aprecia Pharmaceuticals' Spritam. https://www.epmmagazine.com/pharma-manufacturing-news/3d-printed-drug-receives-fda-seal-of-approval/ https://www.epmmagazine.com/pharma-manufacturing-news/3d-printed-drug-receives-fda-seal-of-approval/ Wed, 05 Aug 2015 08:39:00 -0000 Tablets